Our study is the first to demonstrate that TLR4 inhibition increased the cell death of stimulated PBMCs in patients with sepsis and this increased cell death was not via TNF/TNF receptor-mediated apoptotic pathway. The gene discussed is TLR4; the disease is Sepsis.